Funded Tech Companies
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals, based in Cambridge, received equity investments through Wellington Management Company, Bain Capital Life Sciences and Sofinnova Ventures.
Company Overview
Company Name
Alkeus Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2464 Massachusetts Ave 314
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Company Background Information
Overview
Alkeus was co-founded by Leonide Saad, Ph.D. and Ilyas Washington, Ph.D. with the goal of treating degenerative eye diseases in a completely new way: developing a molecule that could reduce the potential for toxicity when vitamin A dimerizes --clumps --in the eye. This dimerization is a key underlying contributor to the irreversible retinal damage that is common to a number of eye diseases. Alkeus has steadily progressed its lead molecule gildeuretinol (ALK-001), demonstrating its tremendous promise and advancing a comprehensive clinical program.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/5/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Joshua Boger
Chief Executive Officer
Leonide Saad
Chief Operating Officer
David Setboun
Co-Founder
Ilyas Washington
Company Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs